Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News Cell Therapy 2014

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

January 26, 2014

Presentation Cell Therapy 2014

Repetitive BMC Therapy in Chronic Heart Failure: Rationale and Design of the REPEAT Trial

Presenter: Birgit Assmus

January 22, 2014

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

Presentation Cell Therapy 2013

Pivotal Study Design and Logistics: The BAMI Study

Presenter: Andreas M. Zeiher

January 24, 2013

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Presentation Cell Therapy 2013

EXCELLENT Trial Design

Presenter: J?r?me Roncalli

January 22, 2013

Presentation Cell Therapy 2013

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Presenter: Jonathan Sackner-Bernstein

January 22, 2013

Presentation Cell Therapy 2012

Design and Rationale for the RENEW Study

Presenter: Thomas J. Povsic

January 26, 2012

Presentation Cell Therapy 2012

ACT 34 CMI Update and Phase 3 Study Design

Presenter: Timothy Henry

January 25, 2012

Advertisement

Repeat Cell Therapy for Chronic Heart Failure Being Tested in Randomized Trials

Repetitive BMC Therapy in Chronic Heart Failure: Rationale and Design of the REPEAT Trial

Small Heart Failure Studies Show Positive Trends for Cell Therapy

Pivotal Study Design and Logistics: The BAMI Study

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

EXCELLENT Trial Design

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Design and Rationale for the RENEW Study

ACT 34 CMI Update and Phase 3 Study Design

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content